Company Directory / Biotechnology Research

Public · NASDAQ:RXRXFor profitBiotechnology ResearchSalt Lake City, Utah, United States
Recursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning.
Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By… Read all
Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale, up to millions of wet lab experiments weekly, and massive computational scale, owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine. Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Toronto, Montréal, New York, London, Oxford area, and the San Francisco Bay area. Learn more at www.Recursion.com, or connect on X (formerly Twitter) and LinkedIn.
Size
501-1000 people: larger than 95% of companies with a size listed. 915 people list it on LinkedIn.
Age
13 years old.
Reach
Website ranked #812,346 in the world for traffic, about 36k visits a month. 65,393 followers on LinkedIn.
Artificial Intelligence (AI)BiotechnologyMachine LearningPharmaceuticalSoftwareTherapeuticsPharmaceuticalsDrug DiscoveryRare DiseasesDrug RepurposingInflammationImmuno-oncologyDiseases of AgingPhenomicsartificial intelligencemachine learningtechnologybiology
Funding, as listed
$865M raised in total
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about Recursion Pharmaceuticals, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
Corporate family
About this record
Growth, as the source summarises it
Recursion Pharmaceuticals reported annual earnings that led analysts to lift their estimates. The company also beat expectations in its first quarter 2024 earnings. Additionally, Recursion Pharmaceuticals made a significant executive hire by bringing in J&J's chief data science officer.
Summaries written by the source dataset, not by us, and not checked.
Biotechnology Research in United States.
Global Blood TherapeuticsSouth San Francisco · 251-500 people · 23k followers
Editas MedicineCambridge · 251-500 people · 49k followers
Cogent BiosciencesWaltham · 101-250 people · 13k followers
CueSan Diego · 1001-5000 people · 23k followersFrom the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.